Related Experiment Videos
Surgical revascularization of acute evolving myocardial infarction without blood cardioplegia fails to restore
Insights
Multidose hypothermic blood cardioplegia offers superior myocardial protection compared to cardiopulmonary bypass alone after coronary occlusion. This method improves heart function and reduces tissue damage during reperfusion, highlighting the importance of cardioplegia composition.
Area of Science:
- Cardiovascular Surgery
- Cardiology
- Biomedical Engineering
Background:
- Coronary occlusion during cardiac procedures can lead to myocardial damage.
- Cardiopulmonary bypass (CPB) is a standard technique, but myocardial protection strategies require optimization.
- Hypothermic blood cardioplegia is an alternative method for myocardial preservation.
Purpose of the Study:
- To evaluate the additional myocardial protection afforded by multidose hypothermic potassium blood cardioplegia compared to CPB alone.
- To assess the impact of different reperfusion strategies on myocardial function and tissue integrity post-ischemia.
Main Methods:
- Anesthetized dogs underwent a one-hour left anterior descending coronary artery occlusion.
- Two groups were formed: one received multidose blood cardioplegia, the other received standard CPB with unmodified blood reperfusion.
- Myocardial function (fractional shortening) and tissue water content were measured post-reperfusion.
Main Results:
- Blood cardioplegia significantly reduced subendocardial water content compared to CPB alone (79.4% vs. 81.5%).
- Fractional shortening recovery was significantly greater with blood cardioplegia (39.3% vs. 6.3% of control).
- Post-ischemic adenosine triphosphate (ATP) levels were similar between groups, suggesting improved salvage beyond ATP levels.
Conclusions:
- Multidose hypothermic blood cardioplegia provides superior myocardial salvage compared to CPB alone following coronary occlusion.
- The composition and delivery conditions of cardioplegia are critical for optimizing myocardial protection during cardiac surgery.
- Further research should focus on refining cardioplegia strategies for enhanced patient outcomes.
Abstract:
This study determines the additional protection provided by multidose hypothermic potassium blood cardioplegia over cardiopulmonary bypass alone following one hour of coronary occlusion. In 19 anesthetized dogs having an open-chest procedure, the left anterior descending coronary artery (LAD) was occluded for one hour, and this resulted in loss of active shortening in the affected zone (sonomicrometry). Cardiopulmonary bypass was established, and the dogs were divided into two groups based on the mode of reperfusion. In 10 dogs, hearts were arrested for one hour with amino acid-enhanced multi-dose blood cardioplegia; the ligatures were removed prior to the second infusion. In the 9 remaining dogs, the ligatures were removed and reperfusion was initiated with unmodified blood on total vented bypass. Both groups were reperfused for one additional hour. Postischemic levels of adenosine triphosphate (ATP) were comparable in the blood cardioplegia and bypass groups, and subendocardial levels averaged 42.8% and 45.8% of controls, respectively. Levels of creatine phosphate returned to control values. Subendocardial water content was significantly less in the blood cardioplegia hearts than the bypass hearts (79.4 +/- 0.5% vs. 81.5 +/- 0.5%; p less than .05); subendocardial water content in the blood cardioplegia group was not different from controls (78.6 +/- 0.1%). Blood cardioplegia restored significantly more fractional shortening than total vented bypass alone (39.3 +/- 9.8% vs. 6.3 +/- 9.1% of control), despite similarities in postischemic levels of ATP. We conclude that blood cardioplegia allows better myocardial salvage in the setting of evolving infarction. Therefore, attention must be directed to both the conditions (bypass, delivery pressure) and composition (cardioplegia) of reperfusion.